Supriya Lifescience - Quaterly Results

24 Jan 2025 Evaluate
The Sales for the quarter ended December 2024 of Rs. 1856.48 millions rose by 32.54% from Rs. 1400.74 millions.Handsome Net Profit growth of 57.05% reported above the corresponding previous quarter figure of Rs. 467.82 millions to Rs. 297.88 millions.Operating Profit saw a handsome growth to 680.50 millions from 445.54 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1856.48 1400.74 32.54 5123.76 4121.90 24.31 5703.70 4609.38 23.74
Other Income 20.98 30.65 -31.55 68.40 84.50 -19.05 106.35 94.89 12.08
PBIDT 680.50 445.54 52.74 2000.51 1261.82 58.54 1836.11 1383.87 32.68
Interest 5.07 4.94 2.63 12.69 17.70 -28.31 21.10 30.84 -31.58
PBDT 675.43 440.60 53.30 1987.82 1244.12 59.78 1815.01 1353.03 34.14
Depreciation 49.64 39.60 25.35 143.64 118.96 20.75 158.11 118.15 33.82
PBT 625.79 401.00 56.06 1844.18 1125.16 63.90 1656.90 1234.88 34.17
TAX 157.97 103.12 53.19 468.43 303.32 54.43 465.76 336.30 38.50
Deferred Tax 20.25 6.57 208.22 29.58 21.76 35.94 94.76 29.49 221.33
PAT 467.82 297.88 57.05 1375.75 821.84 67.40 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 36.66 31.81 15.24 39.04 30.61 27.54 32.19 30.02 7.22

Supriya Lifescience Share Price

643.70 -35.80 (-5.27%)
21-Feb-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1643.05
Dr. Reddys Lab 1151.95
Cipla 1474.30
Lupin 1906.15
Zydus Lifesciences 885.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on